Phase
Condition
Hearing Loss
Neurofibromatosis
Vestibular Hypofunction
Treatment
Experimental treatment: Head movements
Sham treatment: only eye movements
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients with unilateral vestibular schwannoma and programmed surgery
vestibulo-ocular reflex gain :
on pathological side > 0.50
on healthy side > 0.80
all information's concerning the study given more than 15 days before surgery andconsent collected the day before surgery
Exclusion
Exclusion Criteria:
Radiotherapy treatment prior to surgery.
Resumption of surgery
Presence of bilateral vestibular schwannomas
Normal or Corrected to normal distance visual acuity < 5/10
Presence of other aetiologies that may explain the ataxic syndrome and/oroscillopsias
Oculomotor paralysis, ocular instability in primary position
Use of medications that compromise eye movement (psychotropic drugs)
Cervical spinal pathology with instability (contraindication for vHIT)
Cochlear implantation
Non-stabilized medical condition
Pregnant women. This exclusion criterion will be investigated by questioning thepatient.
Patient under guardianship
Patient not affiliated to a social security scheme
Patient participating any other interventional study
Study Design
Connect with a study center
Pierre Wertheimer Hospital - Neurological Hospital
Bron, 69677
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.